Protein: MFM7_PHOSM
Sequence: MSSRPLLKLALSLHDRLDELCSRGQIALVGYGLDVAAVAAVARHECFPIVDDEEVIARLNESTEILERSCRGSTMIYGVHTGFGGSADTRPDDSSGLGRGLMQLLQTGVLVVENLNISGPSTPQIMMPQSMPSSWTKATTAVRINQCVRGHSAIRHQTVKSLLKLVATQITPIVPLRGSISASGDLMPLSYIAGTLEGSPDIYVTKGSGKSAKIISAHEALGEIGMKPLLLGPREGLGLVNGTATSAATASLAVLDAIQLTLLSTGLTCLVSEGMAARVEWLHPFIAETRPHPGQGEVAAIMRAFLKGSRLVSGLEGEANAHLHTLNVRPDEGLPQDRYPLRTSPQWLGPQFEDLLLAHSQITIELNSTSDNPLTNLKTGAMHHGGNFQATSITSAVEKIRTSLQMVGKLLFSQCTEMINHQMNAGLPPNLAADDPSASFCCKGLDINIAAYQSELSYLSNSISNHVQSAEMHNQAVNSLAFLSTRYTIKAIELLGMMVAGVLYAACQAMDLRVMHATFLDTTTSTLQKAIADLLPNGFKSDDVEKSLATAVQGLRNAWWNNAGSDASERCSITAIAFVQVLCDPSKYHTDTHKEDICLDLTAKEMRQLQDDVRLHLSKAYHKHHSAFLEKPTTEEYIGKGSKALYLWTRQDLGIPMNRGLIDHPSPENLKEPGSVGKRTIGSYVSMIYQGIQDGRLFKRFATASREVGLGDGGVNGTRKRAYADYETP
What is the function of this protein?
Phenylalanine ammonia-lyase; part of the gene cluster that mediates the biosynthesis of squalestatin S1 (SQS1, also known as zaragozic acid A), a heavily oxidized fungal polyketide that offers potent cholesterol lowering activity by targeting squalene synthase (SS) (PubMed:27056201).  SQS1 is composed of a 2,8-dioxobicyclic[3. 2. 1]octane-3,4,5-tricarboxyclic acid core that is connected to two lipophilic polyketide arms (PubMed:27056201).  These initial steps feature the priming of an unusual benzoic acid starter unit onto the highly reducing polyketide synthase pks2, followed by oxaloacetate extension and product release to generate a tricarboxylic acid containing product (By similarity).  The phenylalanine ammonia lyase (PAL) M7 and the acyl-CoA ligase M9 are involved in transforming phenylalanine into benzoyl-CoA (By similarity).  The citrate synthase-like protein R3 is involved in connecting the C-alpha-carbons of the hexaketide chain and oxaloacetate to afford the tricarboxylic acid unit (By similarity).  The potential hydrolytic enzymes, M8 and M10, are in close proximity to pks2 and may participate in product release (By similarity).  On the other side, the tetraketide arm is synthesized by a the squalestatin tetraketide synthase pks1 and enzymatically esterified to the core in the last biosynthetic step, by the acetyltransferase M4 (PubMed:11251290, PubMed:15489970, PubMed:28106181).  The biosynthesis of the tetraketide must involve 3 rounds of chain extension (PubMed:11251290, PubMed:15489970, PubMed:28106181).  After the first and second rounds methyl-transfer occurs, and in all rounds of extension the ketoreductase and dehydratase are active (PubMed:11251290, PubMed:15489970, PubMed:28106181).  The enoyl reductase and C-MeT of pks1 are not active in the final round of extension (PubMed:11251290, PubMed:15489970, PubMed:28106181).  The acetyltransferase M4 appears to have a broad substrate selectivity for its acyl CoA substrate, allowing the in vitro synthesis of novel squalestatins (Probable).  The biosynthesis of SQS1 requires several oxidative steps likely performed by oxidoreductases M1, R1 and R2 (Probable).  Finally, in support of the identification of the cluster as being responsible for SQS1 production, the cluster contains a gene encoding a putative squalene synthase (SS) R6, suggesting a likely mechanism for self-resistance (Probable).
What are the official names of this protein?
Phenylalanine ammonia-lyase, PAL, Squalestatin S1 biosynthesis cluster protein M7.
What is the protein family that this protein belongs to?
Belongs to the PAL/histidase family.
What are the subcellular locations of this protein?
Cytoplasm.